Search results for "ST Pharm"

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug application for its dual-antibody...

"K-Health Content for 4.7 Billion People": Kormedi.com Launches Global Multilingual Service

Kormedi.com, South Korea’s premier health and medical media outlet, is officially going global. On March 3, the company launched its multilingual...
SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium

SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium

SK Bioscience announced on February 26th that a tripartite consortium including the company has been selected for the...
Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men

Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men

Tyrosine, an amino acid widely marketed as a cognitive enhancer to sharpen focus, may be linked to a significant...
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple...
VigenCell

VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?

VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
Forget the Pharmacy: Why the ‘Rainbow Diet’ Trumps Antioxidant Pills

Forget the Pharmacy: Why the ‘Rainbow Diet’ Trumps Antioxidant Pills

In large-scale studies conducted by U.S. national institutions and Harvard Medical School—such as the ATBC, CARET,...
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
Zinc for Immunity: Why Long-Term Use Can Trigger Nerve Damage

Zinc for Immunity: Why Long-Term Use Can Trigger Nerve Damage

When it comes to supplements, the "more is better" philosophy can be dangerous. Zinc is widely celebrated as an...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...